Skip to main navigation Skip to search Skip to main content

A Phase II, Double-Blind, Placebo-Controlled, Dose Comparative Study of the Efficacy, Tolerability and Safety of MCC-135 in Subjects with Chronic Heart Failure, NYHA II/III

  • HASAN, MIAN (PI)
  • ABRAHAM, WILLIAM (Former PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/01 → 7/31/03